Naproxen
- TRADE NAMES: Aleve (Bayer); Anaprox; Apranax; Dymenalgit; Flanax; Laraflex; Naprelan; Naprogesic; Napron X; Naprosyn (Roche); Naprosyne; Naxen; Novo-Naprox; Nu-Naprox; Supradol; Synflex (Roche); Velsay
- INDICATIONS: Pain, arthritis
- CLASS: Covid-19 putative drug, Non-steroidal anti-inflammatory (NSAID)
- HALF-LIFE: 15 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Methotrexate, Methyl salicylate, Prednisolone
PREGNANCY CATEGORY: C
Investigated for treating COVID-19.
NSAIDs may cause an increased risk of serious cardiovascular and gastrointestinal adverse events, which can be fatal. This risk may increase with duration of use.
Please login to see the rest of this drug profile
SKIN.
HAIR.
NAILS.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTIC.
RENAL.
RESPIRATORY.
OTHER.
Page last updated 11/18/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric